Elixir Pharmaceuticals' Series D Round

Elixir Pharmaceuticals raised a round of funding on October 11, 2007.

Elixir Pharmaceuticals a Cambridge MA-based biopharmaceutical company focuses on developing and commercializing drugs to treat and prevent metabolic disease and age-related diseases.…

Articles about Elixir Pharmaceuticals' Series D Round: